Fulgent Genetics Profit Margin 2015-2025 | FLGT

Current and historical gross margin, operating margin and net profit margin for Fulgent Genetics (FLGT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Fulgent Genetics net profit margin as of March 31, 2025 is -13.94%.
Fulgent Genetics Annual Profit Margins
Fulgent Genetics Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.523B $0.283B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.442B 59.08
Hims & Hers Health (HIMS) United States $14.813B 153.91
Doximity (DOCS) United States $11.035B 51.09
Tempus AI (TEM) United States $9.797B 0.00
IRhythm Technologies (IRTC) United States $4.475B 0.00
Inspire Medical Systems (INSP) United States $3.673B 57.39
Hinge Health (HNGE) United States $3.507B 0.00
Privia Health (PRVA) United States $2.380B 162.67
10x Genomics (TXG) United States $1.656B 0.00
Phreesia (PHR) United States $1.604B 0.00
Enovis (ENOV) United States $1.531B 8.53
Azenta (AZTA) United States $1.497B 69.57
Schrodinger (SDGR) United States $1.492B 0.00
Clover Health Investments (CLOV) United States $1.471B 0.00
Omnicell (OMCL) United States $1.453B 27.44
Evolent Health (EVH) United States $1.180B 100.50
Claritev (CTEV) United States $0.655B 0.00
Veradigm (MDRX) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.505B 0.00
Butterfly Network (BFLY) United States $0.423B 0.00
Talkspace (TALK) United States $0.407B 121.50
TruBridge (TBRG) United States $0.313B 694.00
Outset Medical (OM) United States $0.285B 0.00
Nyxoah SA (NYXH) Belgium $0.254B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
Zepp Health (ZEPP) Netherlands $0.195B 0.00
CapsoVision (CV) United States $0.179B 0.00
KORU Medical Systems (KRMD) United States $0.160B 0.00
American Well (AMWL) United States $0.115B 0.00
EUDA Health Holdings (EUDA) Singapore $0.114B 0.00
MDxHealth SA (MDXH) Belgium $0.113B 0.00
CareCloud (CCLD) United States $0.101B 3.84
ImmunoPrecise Antibodies (IPA) Canada $0.077B 0.00
Pulmonx (LUNG) United States $0.074B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.072B 0.00
111 (YI) China $0.059B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.038B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Healthcare Triangle (HCTI) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
PROFUSA (PFSA) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00